In vitro Antimicrobial Activity of Fosfomycin, Rifampin, Vancomycin, Daptomycin Alone and in Combination Against Vancomycin-Resistant Enterococci

PURPOSE: The emergence of vancomycin resistant Enterococci (VRE) is shortening the choices for clinical anti-infective therapy. The aim of this study was to investigate the mechanism of vancomycin resistance and evaluate the effect of fosfomycin (FM), rifampin (RIF), vancomycin (VAN), linezolid (LNZ...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Jiepeng, Jiang, Yiheng, Xu, Hao, Jin, Xuehang, Zhang, Li, Ying, Shuaibing, Yu, Wei, Qiu, Yunqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285921/
https://www.ncbi.nlm.nih.gov/pubmed/34285472
http://dx.doi.org/10.2147/DDDT.S315061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285921/
https://www.ncbi.nlm.nih.gov/pubmed/34285472
http://dx.doi.org/10.2147/DDDT.S315061

Ejemplares similares